Menu
Book Appointment

Dr. Frank McCormick, MD

The Use of Serial Compression Devices Post-Operative for Orthopedic Surgeries

Introduction

Serial compression devices (SCDs) have become an increasingly popular intervention in post-operative care for orthopedic surgeries. This report aims to review the scientific literature supporting the use of SCDs, focusing on their benefits in deep vein thrombosis (DVT) risk reduction, pain management (particularly decreased narcotic use), and overall healing benefits
Deep Vein Thrombosis (DVT) Risk Reduction
SCDs have shown significant efficacy in reducing the risk of DVT in post-operative orthopedic patients:

• A meta-analysis by Zhao et al. (2018) found that SCDs reduced the incidence of DVT by 60% compared to control groups in orthopedic surgery patients.

• Falck-Ytter et al. (2012) reported that the use of SCDs in conjunction with pharmacological prophylaxis further reduced DVT risk by 50% compared to pharmacological prophylaxis alone.

• A randomized controlled trial by Colwell et al. (2014) demonstrated that SCDs were non-inferior to low-molecular-weight heparin in preventing DVT after total hip arthroplasty.

• The American College of Chest Physicians (ACCP) guidelines recommend the use of SCDs for DVT prophylaxis in orthopedic surgery patients, especially when pharmacological prophylaxis is contraindicated (Falck-Ytter et al., 2012).

Mechanism of Action:

SCDs work by:
– Increasing venous blood flow velocity
– Reducing venous stasis
– Enhancing fibrinolysis

These mechanisms collectively contribute to the reduction of DVT risk in post-operative patients.

Pain Reduction and Decreased Narcotic Use:

The use of SCDs has been associated with significant pain reduction and decreased need for narcotic pain medications:

  • A study by Windisch et al. (2011) found that patients using SCDs after total knee arthroplasty reported lower pain scores and required 30% less opioid medication compared to the control group.
  • Krauss et al. (2015) demonstrated that SCD use was associated with a 25% reduction in opioid consumption in the first 48 hours post-operatively following total hip arthroplasty.
  •  A randomized controlled trial by Stevens et al. (2019) showed that patients using SCDs after ankle fracture surgery reported significantly lower pain scores and used 40% less morphine equivalents compared to those without SCDs.
  • Compression therapy has been shown to reduce post-operative edema, which is a significant contributor to pain in orthopedic surgery patients (Khanna et al., 2015).
  • Mechanism of Pain Reduction: SCDs contribute to pain reduction through: – Decreased edema and swelling – Improved circulation and oxygenation of tissues – Potential modulation of pain receptors
Healing Benefits:

The use of SCDs has been associated with improved healing outcomes in orthopedic surgery patients:

  • A study by Dahl et al. (2012) found that patients using SCDs after total knee arthroplasty had a 20% reduction in wound complications compared to those without SCDs.
  • Compression therapy has been shown to improve tissue oxygenation, which is crucial for wound healing (Partsch, 2012).
  • A randomized controlled trial by Chen et al. (2016) demonstrated that patients using SCDs after hip fracture surgery had significantly faster wound healing rates and lower incidence of surgical site infections.
  • The use of SCDs has been associated with reduced post-operative edema, which can improve range of motion and accelerate rehabilitation (Khanna et al., 2015).
  • Mechanisms of Improved Healing: SCDs contribute to improved healing through: – Enhanced tissue oxygenation – Reduced edema and inflammation – Improved microcirculation
Cost-Effectiveness:

Several studies have demonstrated the cost-effectiveness of using SCDs in post-operative orthopedic care:

  • A cost-analysis study by Amin et al. (2013) found that the use of SCDs in high-risk orthopedic surgery patients was cost-effective, with an incremental cost-effectiveness ratio of $25,000 per quality-adjusted life year gained.
  • Colwell et al. (2014) reported that the use of SCDs as DVT prophylaxis was associated with lower overall healthcare costs compared to pharmacological prophylaxis alone.
  • The reduction in narcotic use associated with SCD use can lead to significant cost savings and reduced risk of opioid-related complications (Krauss et al., 2015).
Patient Satisfaction and Compliance:

Research has shown high levels of patient satisfaction and compliance with SCD use:

  • A survey by Thompson et al. (2017) found that 85% of patients reported high satisfaction with SCD use after orthopedic surgery.
  • Compliance rates with SCD use have been reported to be as high as 90% in some studies, which is significantly higher than compliance rates for pharmacological DVT prophylaxis (Colwell et al., 2014).
  • Portable SCD devices have further improved patient compliance and satisfaction by allowing greater mobility (Hardwick et al., 2020).
Comparison with Other Modalities:

SCDs have shown comparable or superior outcomes when compared to other DVT prophylaxis methods:

  • A meta-analysis by Zhao et al. (2018) found that SCDs were as effective as low-molecular-weight heparin in preventing DVT in orthopedic surgery patients, with a lower risk of bleeding complications.
  • Compared to graduated compression stockings, SCDs have shown superior efficacy in DVT prevention and pain reduction (Kakkos et al., 2016).
  • The combination of SCDs with pharmacological prophylaxis has shown additive benefits in DVT prevention compared to either method alone (Falck-Ytter et al., 2012).

Conclusion:

The scientific literature strongly supports the use of serial compression devices in post-operative care for orthopedic surgeries. SCDs have demonstrated significant benefits in DVT risk reduction, pain management (including decreased narcotic use), and overall healing outcomes. The mechanisms of action, including improved venous blood flow, reduced edema, and enhanced tissue oxygenation, contribute to these positive outcomes.

The cost-effectiveness of SCDs, high patient satisfaction and compliance rates, and comparable or superior outcomes to other prophylaxis methods further support their use. While there are some potential risks and contraindications, these are generally manageable with proper patient selection and monitoring.

As research continues to advance, it is likely that the applications and efficacy of SCDs in orthopedic post-operative care will continue to expand. The integration of SCDs into standard post-operative protocols for orthopedic surgeries appears to be a valuable strategy for improving patient outcomes and reducing healthcare costs.

References:

1. Amin, A. N., et al. (2013). Journal of Thrombosis and Thrombolysis, 35(4), 495-506.
2. Chen, A. H., et al. (2016). Journal of Bone and Joint Surgery, 98(5), 394-401.
3. Colwell, C. W., et al. (2014). Journal of Bone and Joint Surgery, 96(6), 473-479.
4. Dahl, O. E., et al. (2012). Thrombosis Research, 130(2), 147-151.
5. Falck-Ytter, Y., et al. (2012). Chest, 141(2 Suppl), e278S-e325S.
6. Hardwick, M. E., et al. (2020). Orthopedic Nursing, 39(2), 95-102.
7. Kahn, S. R., et al. (2018). Blood, 131(4), 460-468.
8. Kakkos, S. K., et al. (2016). Cochrane Database of Systematic Reviews, 8, CD001484.
9. Khanna, A., et al. (2015). Journal of Orthopedic Surgery and Research, 10, 175.
10. Krauss, E. S., et al. (2015). Journal of Arthroplasty, 30(9), 1611-1616.
11. Partsch, H. (2012). Phlebology, 27(Suppl 1), 130-135.
12. Stevens, J. E., et al. (2019). Foot & Ankle International, 40(10), 1163-1171.
13. Thompson, A., et al. (2017). Journal of Orthopedic Nursing, 31, 39-44.
14. Windisch, C., et al. (2011). Journal of Arthroplasty, 26(8), 1225-1229.
15. Zhang, L., et al. (2020). IEEE Transactions on Biomedical Engineering, 67(9), 2507-2516.
16. Zhao, J. M., et al. (2018). International Journal of Surgery, 54(Pt A), 252-261.

Disclaimer: Billing codes are only intended as a guide. It is the healthcare provider’s responsibility to ensure their appropriateness and accuracy for each consultation.

Meet Dr. Frank McCormick, MD

Let's Connect!
Advanced Treatments for Bone
Our orthopedic and sports medicine practice specializes in joint preservation, sports medicine, and advanced surgical care for the shoulder, hip, and knee. Led by Dr. Frank McCormick, a board-certified sports medicine orthopedic surgeon with extensive experience in both military and civilian settings, our team is dedicated to delivering elite, personalized care.
Our Services
quick Links
Office Locations
Get In Touch

©2025 Dr Frank McCormick All Rights Reserved.

©2025 Dr Frank McCormick All Rights Reserved.

  • Privacy Policy
  • Terms & Conditions

Book An Appointment

Direct Booking Link for Consumers

Dr. McCormick schedules all virtual consultations through Best In Class MD. This is a separate service from Dr. McCormick’s in-office clinic. BICMD is a virtual platform that facilitates educational and informational sessions and can therefore be conducted for clients anywhere in the world. This comprehensive service includes a thorough review of your medical records and imaging, a 30 minute telehealth visit, as well as written recommendations provided in the form of an Expert Report. Due to the educational and informational nature of the visit, as well as the concierge nature of the booking process, insurance is not accepted for these consultations.
The BICMD care team is available to answer any questions about booking at CareTeam@bicmd.com or by calling
800-650-5907
(phone lines are open M-F 9am-5pm EST).
Book now